幹細胞製造の世界市場レポート 2024年

幹細胞製造の市場規模は近年急速に拡大しています。2023年の157億8,000万米ドルから2024年には173億9,000万米ドルへと、CAGR10.2％で拡大します。このような成長の背景には、バイオテクノロジーの進歩による能力の拡大、幹細胞製造に焦点を当てた研究開発の活発化、臨床試験の進展とその治療への応用、幹細胞の利用を規制する枠組みの確立、幹細胞研究や応用を支えるインフラへの多額の投資などがあります。

幹細胞製造の市場規模は今後数年で急成長が見込まれます。2028年の年間平均成長率（CAGR）は11.2％で、265億5,000万米ドルに成長します。予測期間中に予想される成長の原動力となるのは、幹細胞研究への資金提供や投資の増加、治療への応用範囲の拡大、細胞ベースの治療法の出現と進歩、臨床試験件数の増加とそれに続く承認、患者ごとにカスタマイズされた治療法の開発などです。予測期間中に予測される主な動向には、幹細胞研究における3Dバイオプリンティング技術への注目の高まり、人工多能性幹細胞（iPSC）の継続的な拡大と利用、自動化とロボット工学のプロセスへの統合、幹細胞製造の標準化と拡張性への取り組み、様々な用途での幹細胞の培養と利用を強化するバイオリアクター技術の進歩などが含まれます。

老年人口の増加が幹細胞製造市場の成長を牽引します。老年人口とは、免疫力の低下や加齢によって様々な疾病に罹患することが多い65歳以上の高齢者を指します。慢性疾患の有病率は加齢とともに増加し、幹細胞製造はこのような状況との闘いに有望です。国連経済社会局の2020年9月報告によると、世界の65歳以上人口は2020年の9.3％から2050年には約16.0％に増加すると予測されています。さらに、2021年10月に発表された世界保健機関（WHO）のファクトシートでは、世界の60歳以上の人口は2020年の10億人から2030年には14億人になると予測されています。その結果、老人人口の増加が幹細胞製造市場拡大の原動力となっています。

急成長するバイオテクノロジー産業は、幹細胞製造市場の成長を促進すると予想されます。急速に拡大しているバイオテクノロジー分野は、新技術やソリューションを開発するために生体やその構成要素を利用した幅広い製品やサービスを包含しています。幹細胞製造は、バイオテクノロジーの中でも急成長している領域であり、様々な疾患に対する新しい治療法や治療法を生み出すことで、業界に革命を起こす可能性を秘めています。注目すべきは、2022年3月にAirswiftが報告したバイオテクノロジー企業への投資資本が39.6％増加し、2020年の480億米ドルから2021年には670億米ドルに増加するということです。このようなバイオテクノロジー産業の大幅な成長は、幹細胞製造市場拡大の重要な促進要因となっています。

2023年の幹細胞製造市場において最大の地域は北米でした。欧州は幹細胞製造市場において2番目に大きな地域です。幹細胞製造市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の幹細胞製造市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 消耗品
• 器具
• 幹細胞株
• 世界の幹細胞製造市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 調査用途
• 臨床応用
• 細胞および組織バンキングのアプリケーション
• 世界の幹細胞製造市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 製薬会社およびバイオテクノロジー会社
• 学術機関、調査、受託調査機関
• 病院と外科センター
• 細胞および組織バンク
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の幹細胞製造市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の幹細胞製造市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 幹細胞製造市場の競合情勢
• 幹細胞製造市場の企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Merck Millipore
  • Stemcell Technologies
  • Fujifilm Holdings Corporation
  • Takara Bio Group

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Stem Cell Manufacturing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The stem cell manufacturing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Consumables; Instruments; Stem Cell Lines
• 2) By Application: Research Applications; Clinical Application; Cell and Tissue Banking Applications
• 3) By End User: Pharmaceutical And Biotechnology Companies; Academic Institutes, Research Laboratories And Contract Research Organizations; Hospitals And Surgical Centers; Cell And Tissue Banks; Other End Users
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck Millipore; Stemcell Technologies; Fujifilm Holdings Corporation; Takara Bio Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Stem cell manufacturing involves the technologies required to transition stem cell tissue culture from laboratory settings to clinical applications, ensuring controlled, reproducible, automated, validated, and safe production for therapeutic purposes.

The primary products within stem cell manufacturing comprise consumables, instruments, and stem cell lines. Consumables are utilized in growing new cells within culture media, contributing to applications in drug development, tissue culture, gene therapy, and toxicity testing. These consumables serve diverse purposes across research, clinical applications, and cell and tissue banking. They are used by a range of end-users including pharmaceutical and biotechnology companies, academic institutes, research laboratories, contract research organizations, hospitals and surgical centers, as well as cell and tissue banks.

The stem cell manufacturing market research report is one of a series of new reports from The Business Research Company that provides stem cell manufacturing market statistics, including stem cell manufacturing industry global market size, regional shares, competitors with a stem cell manufacturing market share, detailed stem cell manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell manufacturing industry. This stem cell manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell manufacturing market size has grown rapidly in recent years. It will grow from $15.78 billion in 2023 to $17.39 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth observed during the historical period can be attributed to several factors, including advancements in biotechnology that expanded capabilities, increased research and development initiatives focused on stem cell technologies, the progression of clinical trials and their therapeutic applications, the establishment of regulatory frameworks governing stem cell use, and substantial investments in infrastructure supporting stem cell research and applications.

The stem cell manufacturing market size is expected to see rapid growth in the next few years. It will grow to $26.55 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period is expected to be driven by increased funding and investments in stem cell research, the expanding scope of therapeutic applications, the emergence and advancement of cell-based therapies, a rise in the number of clinical trials and subsequent approvals, and the development of customized and patient-specific therapies. Key trends projected in the forecast period encompass a heightened focus on 3D bioprinting techniques within stem cell research, the continued expansion and utilization of induced pluripotent stem cells (iPSCs), integration of automation and robotics in stem cell manufacturing processes, efforts towards standardization and scalability in stem cell technologies, as well as advancements in bioreactor technology enhancing the cultivation and utilization of stem cells for various applications.

The rise in the geriatric population is set to drive the growth of the stem cell manufacturing market. The term 'geriatric population' pertains to individuals aged 65 and older who often experience various diseases due to compromised immunity and aging. The prevalence of chronic diseases increases with age, and stem cell manufacturing holds promise in combating these conditions. According to the United Nations Department of Economic and Social Affairs' September 2020 report, the global population aged 65 and above is projected to increase from 9.3% in 2020 to approximately 16.0% in 2050. Furthermore, a World Health Organization factsheet from October 2021 projects that there will be 1.4 billion individuals over the age of 60 worldwide by 2030, up from 1 billion in 2020. Consequently, the escalating geriatric population is a driving force behind the expansion of the stem cell manufacturing market.

The burgeoning biotechnology industry is expected to fuel the growth of the stem cell manufacturing market. The biotechnology sector, a rapidly expanding field, encompasses a wide range of products and services utilizing living organisms or their components to develop new technologies and solutions. Stem cell manufacturing, as a rapidly growing domain within biotechnology, has the potential to revolutionize the industry by creating novel therapies and treatments for various diseases. Notably, in March 2022, Airswift reported a 39.6% increase in capital invested in biotech companies, rising from $48 billion in 2020 to $67 billion in 2021. This substantial growth in the biotechnology industry is a key driver behind the expanding stem cell manufacturing market.

Technological advancement stands out as a crucial trend in the stem cell manufacturing market, with various stakeholders focusing on leveraging advanced technologies for sustainability. A noteworthy example is Cellino, a US-based biotech company specializing in stem cell manufacturing, which, in September 2021, integrated AI, machine learning, hardware, software, and lasers to enhance yields and reduce production expenses related to human cell production. This innovative approach eliminates human annotation and unpredictability by utilizing machine learning and AI, illustrating the importance of technological advancements in driving efficiency and progress within the stem cell manufacturing market.

Major companies within the stem cell manufacturing market are actively pursuing the development of innovative products, with a focus on GM-grade protein to attain a competitive advantage. GM-grade protein is a designation indicating that protein powders and related products meet specific standards for quality and safety. A noteworthy example is ACROBiosystems Inc., a US-based provider of recombinant proteins and critical reagents, which, in November 2023, introduced GM-grade DLL4 protein. This recombinant, soluble form of Delta-such as Ligand 4 (DLL4), a crucial signaling molecule in stem cell development and differentiation, signifies a significant milestone for advancing stem cell-based therapies. The availability of GMP-grade DLL4 ensures a high-quality, consistent, and scalable source of this essential protein, known for promoting the self-renewal and expansion of hematopoietic stem cells (HSCs). Its utilization in stem cell cultures enhances the growth and differentiation of HSCs, contributing to advancements in stem cell research and therapies.

In June 2021, Catalent, a New Jersey-based developer and producer of delivery methods for pharmaceuticals, biologics, and consumer health products, executed the acquisition of RheinCell Therapeutics GmbH for an undisclosed amount. This strategic move aimed to expand the creation of upcoming cell treatments and significantly enhance Catalent's capacity for large-scale production. RheinCell Therapeutics GmbH, a Germany-based manufacturer, specializes in GMP-grade human-induced pluripotent stem cells (iPSCs). The acquisition strengthens Catalent's position in the stem cell manufacturing market, emphasizing the importance of securing capabilities in producing high-quality stem cell materials for therapeutic applications.

Major companies operating in the stem cell manufacturing market report are Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Chemical Pharma Co. Ltd., AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group, Vericel Corporation .

North America was the largest region in the stem cell manufacturing market in 2023. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the stem cell manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stem cell manufacturing market consists of sales of adult stem cells (ASCs), human embryonic stem cells (HESCs), induced pluripotent stem cells (iPSCs), and very small embryonic-such as cells. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Stem Cell Manufacturing Market Characteristics

3. Stem Cell Manufacturing Market Trends And Strategies

4. Stem Cell Manufacturing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Stem Cell Manufacturing Market Size and Growth

• 5.1. Global Stem Cell Manufacturing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Stem Cell Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Stem Cell Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Stem Cell Manufacturing Market Segmentation

• 6.1. Global Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Consumables
• Instruments
• Stem Cell Lines
• 6.2. Global Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Research Applications
• Clinical Application
• Cell and Tissue Banking Applications
• 6.3. Global Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic Institutes, Research Laboratories And Contract Research Organizations
• Hospitals And Surgical Centers
• Cell And Tissue Banks
• Other End Users

7. Stem Cell Manufacturing Market Regional And Country Analysis

• 7.1. Global Stem Cell Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Stem Cell Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Stem Cell Manufacturing Market

• 8.1. Asia-Pacific Stem Cell Manufacturing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Stem Cell Manufacturing Market

• 9.1. China Stem Cell Manufacturing Market Overview
• 9.2. China Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Stem Cell Manufacturing Market

• 10.1. India Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Stem Cell Manufacturing Market

• 11.1. Japan Stem Cell Manufacturing Market Overview
• 11.2. Japan Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Stem Cell Manufacturing Market

• 12.1. Australia Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Stem Cell Manufacturing Market

• 13.1. Indonesia Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Stem Cell Manufacturing Market

• 14.1. South Korea Stem Cell Manufacturing Market Overview
• 14.2. South Korea Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Stem Cell Manufacturing Market

• 15.1. Western Europe Stem Cell Manufacturing Market Overview
• 15.2. Western Europe Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Stem Cell Manufacturing Market

• 16.1. UK Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Stem Cell Manufacturing Market

• 17.1. Germany Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Stem Cell Manufacturing Market

• 18.1. France Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Stem Cell Manufacturing Market

• 19.1. Italy Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Stem Cell Manufacturing Market

• 20.1. Spain Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Stem Cell Manufacturing Market

• 21.1. Eastern Europe Stem Cell Manufacturing Market Overview
• 21.2. Eastern Europe Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Stem Cell Manufacturing Market

• 22.1. Russia Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Stem Cell Manufacturing Market

• 23.1. North America Stem Cell Manufacturing Market Overview
• 23.2. North America Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Stem Cell Manufacturing Market

• 24.1. USA Stem Cell Manufacturing Market Overview
• 24.2. USA Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Stem Cell Manufacturing Market

• 25.1. Canada Stem Cell Manufacturing Market Overview
• 25.2. Canada Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Stem Cell Manufacturing Market

• 26.1. South America Stem Cell Manufacturing Market Overview
• 26.2. South America Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Stem Cell Manufacturing Market

• 27.1. Brazil Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Stem Cell Manufacturing Market

• 28.1. Middle East Stem Cell Manufacturing Market Overview
• 28.2. Middle East Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Stem Cell Manufacturing Market

• 29.1. Africa Stem Cell Manufacturing Market Overview
• 29.2. Africa Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Stem Cell Manufacturing Market Competitive Landscape And Company Profiles

• 30.1. Stem Cell Manufacturing Market Competitive Landscape
• 30.2. Stem Cell Manufacturing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck Millipore
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Stemcell Technologies
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Fujifilm Holdings Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Takara Bio Group
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Stem Cell Manufacturing Market Competitive Benchmarking

32. Global Stem Cell Manufacturing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Manufacturing Market

34. Stem Cell Manufacturing Market Future Outlook and Potential Analysis

• 34.1 Stem Cell Manufacturing Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Stem Cell Manufacturing Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Stem Cell Manufacturing Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer